Could a gel help dental implants last longer?
NCT ID NCT07523412
First seen Apr 23, 2026 · Last updated Jun 21, 2026 · Updated 10 times
Summary
This study tests whether adding erythropoietin gel to a standard bone graft helps preserve bone and gum tissue around dental implants placed right after a tooth is pulled. About 26 adults aged 20–50 with a non-restorable front tooth will receive either the gel-plus-graft or graft alone. Researchers will use 3D X-rays and clinical exams to compare bone and gum changes over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERI-IMPLANT BONE AND SOFT TISSUES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ahmed
Cairo, Egypt
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Erythropoietin gel mixed with bone graft (xenograft)
What this could lead to
If it works, this could improve how well bone and gum heal around dental implants, potentially leading to stronger, longer-lasting implants.
What could go wrong
This is a small, early-phase study with only 26 participants, so results may not apply to everyone. The gel is new for this use, and its benefits over standard treatment are uncertain.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.